Navigation Links
Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-1 Specific Peptides
Date:3/19/2013

rtainties and other factors that could cause Palatin's actual results to be materially different from its historical results or from any results expressed or implied by such forward-looking statements. Palatin's actual results may differ materially from those discussed in the forward-looking statements for reasons including, but not limited to, results of nonclinical, preclinical and toxicology studies, result of clinical trials, regulatory actions by the FDA and the need for regulatory approvals, Palatin's ability to fund development of its technology and establish and successfully complete clinical trials, the length of time and cost required to complete clinical trials and submit applications for regulatory approvals, products developed by competing pharmaceutical, biopharmaceutical and biotechnology companies, commercial acceptance of Palatin's products, and other factors discussed in Palatin's periodic filings with the Securities and Exchange Commission. Palatin is not responsible for updating for events that occur after the date of this press release.


'/>"/>
SOURCE Palatin Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Palatin Technologies Announces Last Patient Completed Treatment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial
2. Patient Safety Technologies Reports Fourth Quarter And Fiscal 2012 Results
3. Medbox Acquires 50% of MedVend and its Patented Technologies
4. BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2012 Financial Results
5. SafeCode Drug Technologies Acquires Breakthrough Painless Injection Technology
6. Xyntek-Antares & ESS Technologies to Unveil New Ultra Compact TaskMate(R) Robotic Case Erector / Loader with Track & Trace at Interphex 2013
7. Cylene Pharmaceuticals and TetraGene Enter Agreement for Quarfloxin and Anticancer Quadruplex Technologies
8. Ajinomoto Co., Inc. Agrees To Acquire Althea Technologies, Inc.
9. BioSpecifics Technologies Corp. to Host Conference Call to Report Fourth Quarter and Full Year 2012 Financial Results on Tuesday, March 12, 2013
10. Particle Sciences and NETZSCH Premier Technologies Enter into Collaboration
11. Animas Development of a First-Generation Closed Loop Insulin Delivery System Progresses With Data Presented at the Advanced Technologies & Treatments for Diabetes (ATTD) Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... Calif. , June 30, 2015  Avanir ... PRISM II study showing that treatment with NUEDEXTA ... reduction in symptoms of pseudobulbar affect (PBA) in ... PBA is a distressing condition characterized by sudden ... from certain neurologic diseases or brain injury. PRISM ...
(Date:6/30/2015)... -- July 4 th is this weekend, a time we ... people behind it. To help honor our current nation,s heroes, ... Medical Card, a leading provider of free pharmacy ... independence for our disabled military veterans, police, firemen, and EMS ... prescriptions. "Due to USA ...
(Date:6/30/2015)... 2015 Research and Markets( http://www.researchandmarkets.com/research/pggcjf/global_endoscopy ) ... Endoscopy Devices Market 2015-2019" report to their ... to grow at a CAGR of 5.53% over ... market can be segmented into three based on ... market can be further segments in terms of ...
Breaking Medicine Technology:Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 2Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 3Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 4Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 5Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 6Avanir Pharmaceuticals Announces Positive Top-line Results from Stroke and TBI Cohorts of PRISM II Study 7Hope For Heroes and USA Medical Card Make a Difference for Our Nation's Heroes 2Global Endoscopy Devices Market 2015-2019 - Key Players are Boston Scientific, Johnson and Johnson, Medtronic, Karl Storz & Olympus 2Global Endoscopy Devices Market 2015-2019 - Key Players are Boston Scientific, Johnson and Johnson, Medtronic, Karl Storz & Olympus 3
... that it will report its 2011 first quarter earnings on Friday, ... host an analyst and investor call at 10:00 AM EDT live ... participate in the conference call within the U.S. and Canada, dial ... dial (708) 290-1340. The conference ID is 74735682. ...
... 14, 2011 Cardinal Health today opened its first ... its nationwide capability to manufacture molecular imaging biomarkers that ... cancer, neurological disorders and heart disease. Cyclotrons ... Tomography (PET) molecular imaging agents, one of the fastest-growing ...
Cached Medicine Technology:Cardinal Health Extends Radiopharmaceutical Manufacturing Network, Opening its First Cyclotron in Georgia 2Cardinal Health Extends Radiopharmaceutical Manufacturing Network, Opening its First Cyclotron in Georgia 3
(Date:6/30/2015)... (PRWEB) , ... June 30, 2015 , ... Red ... title in a recent online poll at http://scoutology.com/novaburgerwars and was selected as ... be published in August 2015. , Red Hot & Blue President Randy McCann said, ...
(Date:6/30/2015)... ... June 30, 2015 , ... Independence Day weekend is more than just ... official kick off of July as National Hot Dog Month. Americans are expected to ... other time of the year and enough to stretch from Washington D.C. to Los ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... Northwest ENT and Allergy Center . , Dr. Antunes ... eyelid, reconstructive, sinus and ear procedures. In addition to performing cosmetic and reconstructive ...
(Date:6/30/2015)... ... ... The United Nations Foundation’s Universal Access Project, in partnership with Planned Parenthood Federation ... today. Why We Care Youth serves as a platform for young people living in ... to them, and why U.S. policymakers should care about expanding access around the world. ...
(Date:6/30/2015)... ... 2015 , ... NJ Top Dentist, Dr. Susan Goldfarb, had a very busy ... for members of the Bergen County Dental Society. She does this every year ... for Healthcare Providers. Life Support from Hackensack Hospital provided the instructors and she ...
Breaking Medicine News(10 mins):Health News:Red Hot & Blue BBQ Restaurants Voted "Best Burger" in Virginia and "Best Barbecue" in Texas 2Health News:Red Hot & Blue BBQ Restaurants Voted "Best Burger" in Virginia and "Best Barbecue" in Texas 3Health News:Biggest Hot Dog Weekend of the Year to Kick Off National Hot Dog Month 2Health News:Atlanta Otolaryngologist Dr. Marcelo Antunes Joins Northwest ENT and Allergy Center 2Health News:Atlanta Otolaryngologist Dr. Marcelo Antunes Joins Northwest ENT and Allergy Center 3Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 2Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 3Health News:UN Foundation, Planned Parenthood Federation of America & Sierra Club Launch Why We Care Youth to Amplify Young Voices on Critical Importance of International Reproductive Health and Contraception 4Health News:NJ Top Dentists Presents, Dr. Susan Goldfarb of Advanced Periodontics & Implant Care! 2Health News:NJ Top Dentists Presents, Dr. Susan Goldfarb of Advanced Periodontics & Implant Care! 3
... may be an independent cause of excessive daytime ... occurrences. Researchers from Sweden performed polysomnography testing on ... years. The apnea-hypopnea index (AHI) was calculated, and ... or very often were considered habitual snorers. Habitual ...
... Nov. 11 What would make 100,000 people,stand in ... will be answered November 28, 29 at St. Peter ... in Burlingame on,November 30 when Issam Nemeh, M.D. arrives ... A cardiothoracic anesthesiologist, Dr.,Nemeh has become known as "The ...
... DIEGO, Nov. 11 Orthodontists have been,straightening teeth ... action has a reaction," in which tooth displacement ... the other as well. Use of dental implants ... expediting,treatment times and expanding possibilities for previously untreatable,cases, ...
... Professor Vivien Chen, PhD,. Associate Professor Xiao Cheng Wu, ... ScD, at LSU Health Sciences Center New Orleans School ... most comprehensive assessment of the burden of human papillomavirus ... report, "Assessing the Burden of Human Papillomavirus (HPV)-Associated ...
... Philanthropy Day Celebration Honors City,s Exemplary Orgs., ... ... Red Cross of Greater,Los Angeles will be honored as the Outstanding Volunteer ... at the Beverly Hilton Hotel., This award is given annually to ...
... from dose-ranging study of new,oral anti-coagulant in patients with ... to begin in December., NEW ORLEANS, Nov. 11 ... anti-clotting agent -- rivaroxaban -- designed to,identify doses that ... efficacy,and safety trials. The results of ATLAS ACS-TIMI 46 ...
Cached Medicine News:Health News:Journal CHEST: Nov. highlights 2Health News:A New Meaning of Thanksgiving: Miracles for Many, Prayers for All as Healing Services Come to San Francisco 2Health News:Dental Implants Effective for Orthodontic Treatment 2Health News:LSUHSC public health contributes to estimate of HPV-related cancers 2Health News:LSUHSC public health contributes to estimate of HPV-related cancers 3Health News:LSUHSC public health contributes to estimate of HPV-related cancers 4Health News:American Red Cross of Greater Los Angeles Named Outstanding Volunteer Organization 2Health News:Phase II Trial of Experimental Anti-Coagulant Reports Safety and Outcomes Data 2Health News:Phase II Trial of Experimental Anti-Coagulant Reports Safety and Outcomes Data 3Health News:Phase II Trial of Experimental Anti-Coagulant Reports Safety and Outcomes Data 4
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Medicine Products: